Psoriasis is an immune-mediated disease in which the skin's own signaling makes cells multiply far too fast, and it affects two to three in every hundred people. It reaches beyond the skin to the joints, heart, metabolism, and mood. Most of it is milder plaque disease that clears with a vitamin D and steroid cream.
When it spreads there is a clear ladder above that: narrowband UVB light, then methotrexate, then the IL-17 and IL-23 biologics that clear or nearly clear the skin where older treatments could not. Losing excess weight and stopping smoking add to that treatment; the special psoriasis diets and detoxes sold online do not clear the skin. Effective drugs exist and delay can cause lasting joint damage, so the priority is to start proper treatment early, and to have the joints, blood pressure, cholesterol, and blood sugar checked because the same inflammation raises those risks too.
Practice Ranking
Every practice we track for Psoriasis, ranked by how well the evidence supports it for this condition. Strength describes the evidence, not our endorsement.
4 practices · 1 to start with
| # | Practice | Evidence | Type | Cost | Effort | Results In | Add to plan |
|---|---|---|---|---|---|---|---|
| 1 | Quitting Smoking Smoking raises psoriasis risk with a causal signal; quitting is the clearest self-directed change. | Strong | Pro | Free to $$ | Hard | Days to Longer | |
| 2 | Weight Loss Improves psoriasis severity in people with overweight. | Strong | Self-Directed | Free to $$$ | Moderate to Hard | Weeks to Months | |
| 3 | Alcohol Heavy drinking tracks with worse psoriasis, though whether it causes flares is unsettled; easing back is a reasonable self-directed step. | Moderate | Self-Directed | Free | Moderate to Hard | Weeks to Months | |
| 4 | Cleanses & Detoxes Special psoriasis diets, cleanses and supplement stacks are not supported; weight loss is the diet lever that actually moves the disease. | Emerging | Self-Directed | Free to $ | Easy | Days to Weeks | |
Default order puts the best-supported practices first, with self-directed care ahead of clinical options. Click any row to open the practice.
What It Is
Psoriasis is an immune-mediated disease of the skin. It is not caused by poor hygiene and it is not contagious. It is common, affecting roughly two to three in every hundred people, and it runs in flares and calmer spells.
The cause is an overactive immune system. Signaling molecules called interleukin-23 and interleukin-17 make skin cells multiply far too fast and inflame, so the outer layer that normally renews over about a month turns over in a few days and builds up as a raised, scaly plaque. The same inherited tendency and the same inflammation reach the joints, the arteries, the metabolism, and mood, which is why psoriasis is treated as a whole-body condition.
Psoriasis takes several forms:
- Plaque psoriasis is by far the commonest: raised red patches topped with silvery scale, classically on the elbows, knees, scalp, and lower back. It is the form most of the treatment evidence addresses.
- Guttate psoriasis appears as many small drop-like spots, often in younger people a week or two after a streptococcal throat infection, and often responds well to light treatment.
- Inverse psoriasis sits in the skin folds as smooth red areas without the thick scale, because the folds keep the skin moist.
- Nail changes (pitting, thickening, and an oil-drop discoloration) mark a higher chance of joint involvement.
- Psoriatic arthritis, inflammation of the joints and tendons, affects up to a third of people with psoriasis and usually appears after the skin disease.
What Helps
Psoriasis is one of the conditions where modern treatment changed the outlook completely. The treatments form a clear ladder, from creams to light to the drugs that act on the whole body, and which rung fits depends on how much skin is involved and whether the joints are affected. Weight loss and stopping smoking add to every rung. Each treatment below is graded at the strength of its own evidence.
For limited plaque psoriasis the first-line treatment is a cream, ointment, gel, or foam that combines a vitamin D analogue such as calcipotriol with a steroid. Across a systematic review of 10 trials in 6590 people, the two together cleared plaques more effectively than either component alone, with few side effects, and the same foam used twice a week on the usual trouble spots prevents relapse. The vitamin D component slows the excess skin-cell turnover and the steroid calms the inflammation, so each addresses a different part of the process. Potency and vehicle are matched to the site: a gel or foam for the scalp, and a milder approach for the face and folds.
When psoriasis is too widespread for creams but not yet needing tablets or injections, controlled doses of a specific ultraviolet light called narrowband UVB clear much of it. It is more effective than the older broadband UVB and, unlike the PUVA form, has not been shown to raise skin-cancer risk, which makes it the usual phototherapy of choice. It means a course of sessions two or three times a week, and a supervised home unit can work for people who cannot get to a clinic.
For moderate-to-severe disease the modern injected biologics changed what is possible. In the Cochrane network meta-analysis of systemic treatments (167 trials, 58,912 people), the drugs that block interleukin-17 and interleukin-23, along with the TNF inhibitor infliximab, were the most effective, reaching at least 90% skin clearance far more often than placebo on high-certainty evidence, with no rise in serious side effects over the induction period.
They clear or nearly clear the skin in a large share of people. They are prescribed and monitored by a specialist, and the choice of agent depends partly on whether the joints are also involved.
Methotrexate and the other older systemic tablets still work and are widely used, especially where a biologic is unsuitable or unavailable. In the same network meta-analysis they beat placebo but cleared less skin on average than the biologics, and methotrexate carried the lowest risk of serious side effects of the systemic options. Taken once weekly with folic acid and regular blood tests, methotrexate also treats psoriatic arthritis, which can make it a sensible single choice when both the skin and the joints need treating.
Two lifestyle levers add to medical treatment. About four in five people with psoriasis also carry excess weight, and in a meta-analysis of 13 trials in 1145 adults, losing some of it improved severity scores and raised the chance of a major improvement by about 60% (risk ratio 1.6), and it improved how well the drugs work. Stopping smoking helps too: smoking raises the risk of developing psoriasis and worsens it, and genetic studies point to it being a cause, not merely a marker. Both also address the heart and metabolic risks that come with psoriasis. Emollients and preparations with coal tar or salicylic acid soften and lift scale as adjuncts to the treatments above.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Skin And Hair
Vitamin D analogue plus steroid beats either alone for limited plaque psoriasis (10 trials, 6590 people)
For limited plaque psoriasis the first-line treatment is a cream, ointment, gel or foam combining a vitamin D analogue with a steroid. In the trials the two together worked better than either on its own, and side effects were few.
This systematic review pooled 10 RCTs (6590 participants) of the two-compound calcipotriol/betamethasone dipropionate formulation used for four to eight weeks against calcipotriol or betamethasone alone, with the Psoriasis Area and Severity Index (PASI) as the primary measure. The combination was consistently more effective, once-daily application matched twice-daily, and adverse events were tolerable. Later work (the PSO-LONG trial) showed the foam can also be used twice weekly as proactive maintenance to hold off relapse. The vitamin D analogue slows the excess skin-cell turnover while the steroid calms inflammation, so the two address different parts of the same process.
Match the vehicle and steroid potency to the site: a gel or foam for the scalp, a milder approach for the face and skin folds. It is the first thing to try for plaque psoriasis covering a limited area, and it can be continued twice weekly on the usual trouble spots to keep them clear.
The study · 1
Yan et al., Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: a systematic review · Indian J Dermatol Venereol Leprol 2016;82(2):135-144
IL-17 and IL-23 biologics reach 90% skin clearance far more often than placebo (167 trials, 58,912 people)
For moderate-to-severe psoriasis the modern injected biologics that target IL-17 and IL-23 changed what is possible: they clear or nearly clear the skin in a large share of people, where older treatments could not.
This living Cochrane review pooled 167 RCTs (58,912 randomized participants, 67.2% men, mean age 44.5, mean baseline PASI 20.4). At class level, anti-IL17, anti-IL23, anti-IL12/23 and anti-TNF biologics all beat the older non-biologic systemics for reaching PASI 90. At drug level the most effective versus placebo (all high-certainty) were infliximab, bimekizumab, ixekizumab and risankizumab, with risk ratios roughly 28 to 50. No significant difference in serious adverse events was found between any intervention and placebo during induction, though the review stresses that these short trials (8 to 24 weeks) give limited long-term safety information. The evidence is strongest for induction; ranking for very-long-term use is less certain.
Who this may not transfer to:Trials skewed male (67%) and enrolled fairly young patients with quite severe disease, so the exact response rates may differ in women, older people and milder disease.
These are prescribed and monitored by a specialist for psoriasis that is extensive or unresponsive to topicals and phototherapy. Which agent suits a given person depends on other conditions, including psoriatic arthritis, so the choice is a clinic conversation rather than a fixed ranking.
The study · 1
Sbidian et al., Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis (Cochrane review) · Cochrane Database Syst Rev 2022;5:CD011535
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Weight loss improves psoriasis severity and raises the chance of a major improvement by about 60% (13 trials, 1145 people)
About four in five people with psoriasis also carry excess weight, and losing some of it improves the skin. Across the trials, weight loss lowered severity scores and raised the chance of a major improvement by about 60% (risk ratio 1.6), and it makes the drug treatments work better too.
This meta-analysis pooled 13 RCTs (1145 participants, mean weight change -14.8 lb (-6.7 kg)), most using dietary change with or without physical activity, three using weight-loss medication. Weight loss improved PASI (MD -2.5), the likelihood of PASI 75 (RR 1.6) and quality of life (DLQI -5.0), across trials that varied substantially in method, and the authors concluded weight-loss support should be part of routine psoriasis care in people with overweight. Excess adipose tissue produces inflammatory signals that feed the same pathways as psoriasis, which is the plausible mechanism, and in psoriatic arthritis a 5% loss improves the response to TNF inhibitors. Weight loss is one of the few lifestyle measures with trial-grade support for the skin itself.
If you carry excess weight, treating that alongside the skin is worthwhile in its own right: it improves the psoriasis, sharpens how well medication works, and addresses the heart and metabolic risks that accompany psoriasis. It complements medical treatment rather than replacing it.
The study · 1
Morrow et al., Impact of weight-loss interventions on psoriasis severity: a systematic review and meta-analysis · J Eur Acad Dermatol Venereol 2026;40(6):980-993
Narrowband UVB clears widespread psoriasis and is safer than PUVA
When psoriasis is too widespread for creams, controlled doses of a specific ultraviolet light called narrowband UVB clear much of it. It is more effective than the older broadband UVB and safer than the PUVA form, and a home unit can work for people who cannot get to a clinic.
This Ontario Health systematic review and health technology assessment appraised NB-UVB against comparators for photoresponsive skin disease, graded with the Cochrane risk-of-bias tool and GRADE. NB-UVB was more effective than broadband UVB and, unlike PUVA, has not been shown to raise skin-cancer risk, making it the usual phototherapy of choice; supervised home treatment was found effective and cost-effective for suitable patients. Phototherapy works by dampening the overactive skin immune response (inhibiting the Th1 and Th17 pathways and slowing keratinocyte proliferation). It needs a course of sessions two to three times a week and is a step between topicals and systemic drugs.
It suits psoriasis too extensive for creams but not yet needing systemic drugs. It is a time commitment of repeated sessions rather than a one-off, and a home unit under medical supervision is worth asking about if travel to a clinic is the barrier.
The study · 1
Ontario Health (Quality), Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: a Health Technology Assessment · Ont Health Technol Assess Ser 2020;20(12):1-134
Methotrexate clears less skin than the biologics but has the lowest serious-side-effect risk of the systemics
Methotrexate and the other older systemic tablets still work for moderate-to-severe psoriasis and are widely used, especially where biologics are unsuitable or unavailable. They clear less skin than the biologics on average, but methotrexate has the most reassuring serious-side-effect record of the systemic options.
Within the Cochrane NMA of 167 trials, non-biologic systemics (methotrexate, cyclosporine, acitretin, fumaric acid esters) and the small molecules apremilast and tofacitinib were significantly better than placebo for PASI 90 but ranked below the biologics; apremilast, cyclosporine and methotrexate did not differ significantly from each other. Methotrexate had a significantly lower risk of serious adverse events than most other interventions (high-certainty versus placebo). Methotrexate needs blood-count and liver monitoring and is avoided in pregnancy; cyclosporine is useful for rapid short-term control; acitretin suits some pustular and hyperkeratotic disease. These remain first-choice systemic options in many settings on grounds of access, cost and familiarity.
Methotrexate is a reasonable first systemic step where a biologic is not the right fit, taken once weekly with folic acid and regular blood tests. It also treats psoriatic arthritis, which can make it a sensible single choice when both skin and joints are involved.
The study · 1
Sbidian et al., Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis (Cochrane review) · Cochrane Database Syst Rev 2022;5:CD011535
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Smoking raises the risk of psoriasis (HR 1.47), and genetic studies support cause
Smoking raises the risk of developing psoriasis and worsens it, and the heavier and longer the smoking, the greater the risk. Genetic studies point to smoking being a cause rather than only a marker, so stopping is one of the clearer things within a person's control.
The Taiwan National Health Interview Survey cohort (60,136 people, 242 incident psoriasis cases) found current smoking associated with incident psoriasis (adjusted HR 1.47), with a dose-response by cigarettes per day and pack-years, after adjusting for demographics and comorbidities. Because smokers differ from non-smokers in many ways, a Mendelian randomization study, which uses inherited genetic variants as a natural experiment less prone to confounding, was used to test causality and found smoking initiation, cigarettes per day and lifetime smoking all causally raised psoriasis risk. Smoking also predicts more severe disease and poorer treatment response. A prospective cohort and a genetic causal analysis point the same way, which is stronger evidence than association alone.
Stopping smoking is worth doing for the psoriasis as well as the heart and lungs. Benefits build over time, and in one cohort former moderate smokers had a lower risk than current smokers, so it is not too late to help.
The studies · 2
Dai et al., Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study · J Am Acad Dermatol 2019;80(3):727-734
Wei et al., Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study · Br J Dermatol 2022;187(5):684-691
Heavy drinking is associated with psoriasis, but whether alcohol causes it is unsettled
Heavy drinking is associated with psoriasis and heavier intake tracks with worse disease, but whether alcohol causes it is unclear, because the link is confounded by smoking. Cutting down is still sensible, both because drinkers with psoriasis have a raised risk of alcohol-related harm and because heavy drinking can worsen flares.
The dose-response meta-analysis (48 studies, 1.7 million people) found a positive association overall (OR 1.47), stronger in men and above about 45 g of alcohol a day, with roughly a 4% higher odds per additional daily gram. But causation is contested: a Mendelian randomization study found no causal effect of alcohol on psoriasis, and in the Women's Health Initiative cohort the apparent alcohol association vanished once smoking was accounted for, suggesting confounding by smoking rather than a direct effect. This is why the direction is left unsettled. Separately, people with psoriasis carry a higher risk of alcohol-related death, so screening and support around drinking matter regardless of the causal question.
Who this may not transfer to:The association was statistically significant in men (OR 1.84) but not in women (OR 1.22), so the strength of any link appears to differ by sex.
There is no need to frame a single drink as dangerous, but keeping within low-risk limits is reasonable, more so if drinking is heavy or if a flare follows it. If alcohol has become a way of coping with the condition, that is worth raising with a clinician.
The study · 1
Choi et al., Dose-response analysis between alcohol consumption and psoriasis: a systematic review and meta-analysis · J Dtsch Dermatol Ges 2024;22(5):641-652
Special psoriasis diets, detoxes and supplements are not supported; weight loss is the diet lever
The diet change that helps psoriasis is losing excess weight if you carry it. The specific psoriasis diets, detox plans and supplement stacks sold online do not have the evidence behind them, and cutting foods out for no clear reason risks nutrition without helping the skin.
The National Psoriasis Foundation dietary systematic review graded the evidence across interventions. The strongest, and the one it recommended, was a hypocaloric diet to lose weight in people with psoriasis who are overweight, which improves severity. For gluten-free diets it advised a trial only in people with confirmed gluten sensitivity or celiac disease; for most other diets, detoxes and supplements (including vitamin D in people with normal levels) the evidence was too weak to recommend them as treatments for the skin. A separate review reached the same conclusion, that weight loss with a healthy lifestyle is the beneficial nutritional strategy while routine supplementation in replete people is not recommended. The reading that fits the evidence is that nutrition matters chiefly through weight and general health rather than through a special anti-psoriasis menu.
Put the effort into an overall healthy pattern and, if you carry excess weight, into losing some, rather than into a branded psoriasis diet or a supplement regimen. Only cut out a food group for a diagnosed reason such as celiac disease, and check vitamin D by a blood test rather than supplementing on spec.
The study · 1
Ford et al., Dietary recommendations for adults with psoriasis or psoriatic arthritis from the Medical Board of the National Psoriasis Foundation: a systematic review · JAMA Dermatol 2018;154(8):934-950
Oral Chinese herbal medicine matched the retinoid acitretin in trials (25 studies)
Chinese herbal formulas showed a signal in the trials: taken orally they matched the prescription retinoid acitretin, and added to it they did a little better, with side effects no worse. It is a promising signal rather than settled proof, and the quality of the studies limits how far to lean on it.
This meta-analysis pooled 25 RCTs: 8 compared oral Chinese herbal medicine (CHM) with acitretin, 12 compared the combination with acitretin alone, and 5 were three-arm. Oral CHM was neither superior nor inferior to acitretin on PASI and produced an add-on effect when combined with it, while appearing to reduce some of acitretin's adverse events. Trials of herbal bath and topical therapy against calcipotriol report broadly similar findings with generally low-to-moderate certainty. The evidence is limited by small, mostly single-region trials, varied and non-standardized formulas, and inconsistent outcome reporting, and long-term efficacy and safety were not established. Chinese medicine treats psoriasis by pattern rather than as one disease, so any formula is meant to be matched to the individual by a practitioner.
Who this may not transfer to:The trials were almost all conducted in China and did not report results by sex, so how far the formulas and findings transfer to other populations and to each sex is not established.
If you want to explore herbal treatment, do it through a qualified practitioner using a traceable supply, and keep it alongside rather than instead of the treatments with the strongest evidence, especially for extensive disease or when the joints are involved. Herbal products bought unlabeled online carry a substantial risk of adulteration.
The study · 1
Zhang et al., Is oral Chinese herbal medicine beneficial for psoriasis vulgaris? A meta-analysis of comparisons with acitretin · J Altern Complement Med 2016;22(3):174-188
Inflammatory Arthritis
A delay over 6 months to a rheumatologist raised joint-erosion odds to 4.25
Up to a third of people with psoriasis develop psoriatic arthritis, and the skin usually comes first, which gives a chance to catch the joint disease early. Even a six-month delay in getting assessed made lasting joint damage and disability more likely.
In this cohort of 283 patients meeting CASPAR criteria, those seen by a rheumatologist beyond 6 months of symptom onset were far more likely to have peripheral joint erosions (OR 4.25) and worse Health Assessment Questionnaire scores (OR 2.2) on multivariable analysis. Because psoriatic arthritis erodes joints permanently and skin psoriasis predates it in roughly 80% of cases, the interval between skin and joint disease is a window for early treatment. Early clues are often non-specific: morning stiffness, a swollen finger or toe (dactylitis), heel or tendon pain (enthesitis), or nail changes. Screening tools exist to flag who should be referred, and effective treatments can prevent progression if started before damage is set.
New or persistent joint pain, stiffness that is worse in the morning, a whole finger or toe that swells, or heel pain deserves assessment rather than waiting. Raising it early is the point, because the damage that a delay allows does not reverse.
The studies · 2
Haroon et al., Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis · Ann Rheum Dis 2015;74(6):1045-1050
Perez-Chada et al., Psoriatic arthritis: a comprehensive review for the dermatologist part I · J Am Acad Dermatol 2025;92(5):969-982
Heart And Vascular
Psoriasis raises heart-attack, stroke and cardiovascular-death risk (up to 1.46), more in severe disease
Psoriasis is not only skin-deep: it is linked to a modestly higher risk of heart attack, stroke and other cardiovascular problems, and more so when the disease is severe. That is a reason to look after blood pressure, cholesterol and the other heart risks, not a cause for alarm.
This meta-analysis pooled 31 cohort studies (665,009 psoriasis patients). Pooled relative risks were 1.17 for myocardial infarction, 1.19 for stroke, 1.46 for cardiovascular death, 1.17 for ischemic heart disease, 1.36 for thromboembolism and 1.35 for arrhythmia, with severe disease carrying more risk than mild. The shared systemic inflammation of psoriasis is the leading explanation, alongside the higher rates of obesity, smoking and metabolic syndrome that accompany it. The absolute increase for any individual is small, but at population scale it is meaningful, and guidelines recommend that people with psoriasis, especially severe or long-standing disease, have their cardiovascular risk factors assessed and managed.
The practical step is ordinary and effective: have blood pressure, cholesterol and blood sugar checked, and treat what is raised. Not smoking, staying active and keeping weight in a healthy range lower this risk and help the skin at the same time.
The study · 1
Liu et al., Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort studies · Front Cardiovasc Med 2022;9:829709
Blood Sugar
Psoriasis carries about 1.42 times the odds of metabolic syndrome
People with psoriasis are more likely to have metabolic syndrome, the cluster of raised blood pressure, blood sugar, waist size and blood fats that drives diabetes and heart disease. Getting screened for these matters, because catching and treating them protects long-term health.
The larger meta-analysis (35 studies, 1.45 million participants) found pooled odds of metabolic syndrome of 2.14 in psoriasis, though publication bias was present. A more conservative meta-analysis limited to studies that adjusted for confounders found an odds ratio of 1.42, and metabolic syndrome was present in about 31% of psoriasis patients. The link is bidirectional: the inflammation of psoriasis and the inflammation of excess adipose tissue reinforce each other, and obesity both raises the risk of psoriasis and worsens it. The clinical message from the reviews is consistent, to screen psoriasis patients for the components of metabolic syndrome (blood pressure, glucose, lipids, waist circumference).
Ask for the simple checks, blood pressure, a fasting glucose or HbA1c, a lipid panel and waist measurement, and act on what is off. Losing excess weight improves the psoriasis and the metabolic picture together, which is why it deserves priority.
The studies · 2
Singh et al., An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies · PLoS One 2017;12(7):e0181039
Rodriguez-Zuniga & Garcia-Perdomo, Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome · J Am Acad Dermatol 2017;77(4):657-666
Mood & stress
Depression is more common in psoriasis, most in severe disease (HR 1.50)
Psoriasis affects mood as well as skin, and people with it face a higher risk of depression, more so when the disease is severe. This is part of the condition to take seriously, and asking about mood is a normal part of good psoriasis care.
This Danish register cohort (247,755 psoriasis patients, matched controls, up to 20 years follow-up) found adjusted hazard ratios for depression of 1.19 for mild, 1.19 for moderate and 1.50 for severe psoriasis, highest in those aged 40 to 50 with severe disease. An earlier Danish cohort found the risk was largely mediated by comorbidities except in younger people with severe disease, where psoriasis itself appeared to contribute, so how much is due to psoriasis itself and how much to its accompanying conditions is debated. The visible, chronic, itchy and stigmatized nature of psoriasis, its systemic inflammation and its comorbidities all plausibly contribute. Trial evidence shows mood scores improve when the skin is treated effectively with targeted therapy.
If low mood, loss of interest or hopelessness are present, they deserve attention in their own right; treating the psoriasis well often lifts mood, and effective help for depression exists alongside it. Raise it with whoever manages the skin.
The studies · 2
Egeberg et al., Risk of first-time and recurrent depression in patients with psoriasis: a population-based cohort study · Br J Dermatol 2019;180(1):116-121
Jensen et al., Psoriasis and new-onset depression: a Danish nationwide cohort study · Acta Derm Venereol 2016;96(1):39-42
How it works
Psoriasis is an IL-23 and IL-17 immune disease, not an infection or hygiene problem
Psoriasis is not a skin infection or a hygiene problem and it is not contagious. It is an immune-driven disease: signaling molecules called IL-23 and IL-17 push skin cells to multiply far too fast and inflame, which is why the drugs that block those signals work so well and why the disease affects more than the skin.
Genetic and experimental work places the IL-23/Th17 axis at the center of psoriasis. IL-23 drives T-helper-17 cells to release IL-17, which acts on keratinocytes, neutrophils and other cells to produce the scaling, redness and rapid skin-cell turnover of a plaque. Susceptibility loci including HLA-C*06:02, IL23A, IL12B and IL17RA sit on this pathway. In the imiquimod mouse model, psoriasis-like inflammation was almost entirely prevented in animals deficient in IL-23 or the IL-17 receptor, demonstrating the axis is necessary rather than incidental. This mechanism explains both why biologics targeting IL-17 and IL-23 clear the skin and why psoriasis behaves as a systemic inflammatory disease with joint, heart and metabolic links rather than a local rash.
The studies · 2
Blauvelt & Chiricozzi, The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis · Clin Rev Allergy Immunol 2018;55(3):379-390
van der Fits et al., Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis · J Immunol 2009;182(9):5836-5845
What Does Not Help
Two popular ideas absorb effort and money without clearing the skin. The diet change that helps psoriasis is losing excess weight, if you carry it. Beyond that, the National Psoriasis Foundation reviewed the evidence and found the specific psoriasis diets, detox regimens, and most supplements too weak to recommend as treatments for the skin. A gluten-free trial makes sense only for someone with confirmed gluten sensitivity or celiac disease, and vitamin D is checked with a blood test, not taken on spec, because supplementing people whose levels are already normal does not help the plaques. Cutting out food groups for no diagnosed reason risks poorer nutrition without helping the skin.
The evidence on alcohol is unsettled. Heavy drinking is more common in people with psoriasis and tracks with worse disease, but whether it causes psoriasis is uncertain, because the link is confounded by smoking: a genetic causal analysis found no direct effect, and in one large cohort the association disappeared once smoking was accounted for. Keeping within low-risk limits is still sensible, both because people with psoriasis carry a raised risk of alcohol-related harm and because a heavy drinking session can precede a flare.
Topical creams alone will not control extensive psoriasis. Expecting them to is the usual reason widespread disease drags on, when the step up to phototherapy or a systemic drug is what it needs.
Beyond the Skin
Psoriasis is a systemic disease, so good care looks beyond the plaques. Up to a third of people with it develop psoriatic arthritis, and because the skin disease usually comes first, there is a window to catch the joint disease early.
In one cohort, a delay of more than 6 months from the first symptoms to seeing a rheumatologist raised the odds of lasting joint erosions to 4.25 and of worse physical function.
New or persistent joint pain, morning stiffness, a whole finger or toe that swells, or heel and tendon pain all deserve prompt assessment.
The inflammation also affects the heart and the metabolism. A meta-analysis of 31 cohort studies (665,009 people with psoriasis) found modestly raised risks of heart attack, stroke, and cardiovascular death, higher when the disease is severe, and people with psoriasis carry about 1.42 times the odds of metabolic syndrome, the cluster of raised blood pressure, blood sugar, waist size, and blood fats. The step here is ordinary: have blood pressure, cholesterol, and blood sugar checked, and treat what is raised.
Depression is more common with psoriasis, more so in severe disease. Treating the skin well often lifts mood, alongside whatever help is given for the low mood itself.
How It Works
Psoriasis is driven by an overactive immune pathway. Interleukin-23 prompts a set of immune cells called T-helper-17 cells to release interleukin-17, which acts on skin cells to produce the rapid turnover, scaling, and redness of a plaque. Inherited susceptibility raises the risk, and triggers such as a throat infection, skin injury, stress, and certain drugs can set the process going in someone predisposed. In a mouse model, psoriasis-like skin disease was almost entirely prevented in animals lacking interleukin-23 or the interleukin-17 receptor, which shows the pathway is central.
This mechanism is why the treatments that work target the pathway, and why the disease reaches beyond the skin. The biologics block interleukin-17 and interleukin-23 directly, which is why they clear the skin so well. The same signaling that inflames the skin also inflames the joints and the arteries, so psoriasis behaves as a whole-body inflammatory disease, and the heart, metabolic, and joint checks are part of its care. The mechanism also explains why psoriasis is not an infection: it is not caused by poor hygiene, and it cannot be caught from someone who has it.
Go Deeper
- Losing excess weight and a whole-food pattern: the eating pattern behind the one diet lever the trials support, without the risks of cutting whole foods out on a hunch.
- A Mediterranean way of eating: the anti-inflammatory pattern that supports weight and cardiometabolic health, the systemic side that comes with psoriasis.
- Walking and regular activity: the free lever for weight and the cardiovascular risk that runs higher in psoriasis.
- Strength training: building and keeping muscle for weight control and metabolic health, an adjunct to weight loss.
- Vitamin D: where a supplement fits, and why it is checked with a blood test, not taken on spec, in psoriasis.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine calls psoriasis Bai Bi and has never read it as one thing. It differentiates by how the skin behaves, hot and rapidly spreading against dry and long-standing, and the pattern points to the direction of treatment. This is an interpretive lens on constitution and the behavior of the skin, not a reading of the interleukin-23 and interleukin-17 immune pathway, and the two describe much of the same condition in different terms. A qualified practitioner working from a traceable herbal supply is the right way to use it, because pattern diagnosis depends on an in-person assessment. Two cautions sit alongside it: modern treatments clear this disease and delay can cause lasting joint damage, so herbal treatment is best kept as an addition to the treatments with the strongest evidence, especially for extensive disease or when the joints are involved; and marketed herbal skin products have a documented history of adulteration with undeclared drugs, so provenance matters as much as the herb.
The acute, actively spreading picture: bright red new plaques appearing quickly, with itch and heat, often in early or flaring disease. The classical direction is to cool the Blood and clear heat.
The chronic, stable picture: dull, thickened, dry and scaly plaques present a long time. Chinese medicine reads this as too little Blood to moisten the skin, and the direction is to nourish Blood and moisten dryness.
Long-standing, well-defined, dark or dusky plaques that are thick and resistant to treatment. The direction is to invigorate the Blood and resolve stasis.
Plaques in the folds or lower body, sometimes weepy or pustular, that feel hot and heavy and can accompany joint involvement. The direction is to clear heat and drain damp.
The trial evidence is early. A meta-analysis of 25 randomized trials found oral Chinese herbal medicine neither better nor worse than the prescription retinoid acitretin on the standard severity score, with an added benefit when the herbs were combined with acitretin and side effects no worse. It is a promising signal, limited by small, mostly single-region trials with varied formulas, so it belongs alongside the treatments with the strongest evidence, not instead of them.
Cautions
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Erythrodermic and generalized pustular psoriasis are medical emergencies
A systematic review of erythrodermic psoriasis describes redness and scaling over more than 75% of the body surface with systemic features, lymphadenopathy, fever, fatigue, dehydration, electrolyte disturbance and tachycardia, that make it potentially life-threatening; it needs prompt systemic treatment, with cyclosporine and infliximab useful for rapid control and methotrexate for maintenance, and newer IL-17 and IL-23 biologics showing high response rates. Generalized pustular psoriasis is a distinct, uncommon variant of sterile pustules over inflamed skin, frequently with fever and systemic inflammation, that can lead to serious complications and is treated as an emergency with systemic agents. Both can be triggered by abruptly stopping systemic steroids, infection or other stresses, and both can be mistaken for other severe skin reactions, so urgent specialist assessment is the safe course.Mastorino et al., Management of erythrodermic psoriasis with systemic therapies: a systematic reviewKearns et al., Review of treatments for generalized pustular psoriasis
Getting the topical steroid right
The vitamin D and steroid creams are matched to the site: a gel or foam for the scalp, and a milder approach for the face, eyelids and skin folds, where prolonged strong steroids can thin the skin. Used as directed on active plaques, and stepped down as they settle, they are effective and well tolerated. If you find yourself using a strong steroid continuously on a delicate area, that is the point to review the plan with a clinician.
The systemic drugs are specialist-monitored
Methotrexate needs blood-count and liver monitoring and is avoided in pregnancy, and cyclosporine is a short-term option because of its effect on the kidneys and blood pressure. The biologics are screened for infection such as tuberculosis before starting and monitored during treatment. These are prescribed and followed by a specialist, and the choice weighs how much skin and which joints are involved against the safety profile of each drug.
Unlabeled herbal creams and hidden drugs
Some marketed herbal skin products, particularly unlabeled or imported ones, have been found adulterated with undisclosed potent steroids or other drugs. That means an unverified product can be far stronger, or far riskier, than it appears. If you want to explore herbal treatment, use a qualified practitioner and a regulated, traceable supply rather than a cream bought online, and have anything that works suspiciously well reviewed.
Psoriasis is common and, for most people, well controlled with the treatments on this page. None of this is meant to frighten you off treatment. These notes are here to help you use the effective options confidently and to know which situations call for a professional.
When to See Someone
Most psoriasis is managed with the creams, light and medication above and never becomes an emergency. This is the When to See Someone list to come back to, and the first three need urgent, often same-day, care:
- Psoriasis turning the skin red and scaly over almost the whole body, especially with fever, shivering, feeling unwell or a fast heartbeat. This can be erythrodermic psoriasis, which disturbs temperature and fluid balance and is a medical emergency(seek urgent care)
- A sudden, widespread eruption of small pus-filled spots on red, inflamed skin, often with fever and feeling unwell. This can be generalized pustular psoriasis, a medical emergency(seek urgent care)
- Signs of a spreading skin infection: increasing pain, warmth, swelling, yellow crusting or fever over affected skin(seek urgent care)
- New or persistent joint pain, swelling or morning stiffness, a whole finger or toe that swells, or heel and tendon pain. This can be psoriatic arthritis, and being seen early protects the joints from lasting damage
- Psoriasis that is spreading fast, covering a large area, or not improving despite using the treatments correctly, which may mean it is time for phototherapy or a systemic drug
- New or worsening psoriasis soon after starting or stopping a medication, since some drugs trigger it and abruptly stopping others can set off a severe flare
- Low mood, loss of interest, hopelessness, or thoughts of self-harm. Depression is more common with psoriasis and deserves attention in its own right; if there are thoughts of self-harm, seek help straight away
- Never had the cardiovascular and metabolic checks: blood pressure, cholesterol and blood sugar are due for review, particularly with severe or long-standing psoriasis
None of this is meant to alarm you. Psoriasis is common, it is manageable, and for most people it is controlled well with the treatments on this page. Knowing the few forms and signs that need prompt care, and the checks to have, is simply part of managing it with confidence.
Common Questions
Is psoriasis curable?
Not yet, but it is highly treatable, and for many people the skin can be cleared or nearly cleared. Mild plaque psoriasis is controlled with a vitamin D and steroid cream, more widespread disease with narrowband UVB light, and moderate-to-severe disease with methotrexate or the IL-17 and IL-23 biologics, which reached at least 90% skin clearance far more often than placebo in the trials. The aim is long, well-controlled stretches with the least treatment that holds the skin, and losing excess weight and stopping smoking help the medical treatment work.
Is psoriasis contagious or caused by poor hygiene?
No. Psoriasis is an immune-mediated disease in which interleukin-23 and interleukin-17 push skin cells to multiply far too fast and inflame. It is not a skin infection, it is not caused by being unclean, and it cannot be passed to anyone else. Inherited susceptibility raises the risk, and triggers such as a throat infection, skin injury, stress or certain drugs can set it going.
Does diet help psoriasis?
The diet change with the strongest support is losing excess weight, if you carry it, which improved severity and raised the chance of a major improvement by about 60% (risk ratio 1.6) across 13 trials. Beyond that, the special psoriasis diets, detoxes, and supplement stacks sold online do not have the evidence behind them, and cutting out food groups for no diagnosed reason risks poorer nutrition without helping the skin. A gluten-free trial makes sense only with confirmed gluten sensitivity or celiac disease, and vitamin D is checked with a blood test, not taken on spec.
Why does my doctor keep checking my heart and joints?
Because psoriasis reaches past the skin. The same inflammation is linked to a higher risk of heart attack, stroke and metabolic syndrome, and up to a third of people with psoriasis develop psoriatic arthritis. Catching the joint disease early protects the joints, because even a delay of more than 6 months to a rheumatologist raised the odds of lasting joint damage. Blood pressure, cholesterol and blood sugar checks, and attention to any new joint pain, are a normal part of good psoriasis care.
When should psoriasis be seen the same day?
The two to know are erythrodermic psoriasis, when the skin turns red and scaly over almost the whole body with fever or feeling very unwell, and generalized pustular psoriasis, a sudden spread of small pus-filled spots on red skin with fever. Both are medical emergencies. A spreading skin infection, with increasing pain, warmth, swelling or yellow crusting, also needs same-day care. These and the rest are gathered in the When to See Someone section above.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 21 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.